ANDA 76604, held by Actavis Labs Fl Inc. Hydrocodone Bitartrate; Ibuprofen.
As of Nov 16, 2026, ANDA 76604 (Hydrocodone Bitartrate And Ibuprofen), held by Actavis Labs Fl Inc, was first approved by FDA on Dec 31, 2003, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 31, 2003 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrocodone Bitartrate And Ibuprofen7.5MG;200MG · tablet;oral | Hydrocodone Bitartrate; Ibuprofen | Rx |
| Jun 18, 2026 | Supplement 32REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 31Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 30Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 29REMS | Approved | None posted |
| Oct 3, 2024 | Supplement 28Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 26Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 27Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 25Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 24Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 23Labeling · Standard review | Approved | None posted |
| Aug 23, 2019 | Supplement 22Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 20REMS | Approved | None posted |
| Mar 22, 2017 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 22, 2017 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jul 31, 2010 | Supplement 15Labeling | Approved | None posted |
| Aug 22, 2007 | Supplement 4Labeling | Approved | None posted |
| Dec 31, 2003 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters